Juergen Wolf
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 5%
- Viral-associated cancers and disorders
- CAR-T cell therapy research
Papers in
- Oncology 23
- Viral-associated cancers and disorders 10
- Lung Cancer Research Studies 7
- Cancer Immunotherapy and Biomarkers 3
-
- Lymphoma Diagnosis and Treatment 16
- Co-authors
- Volker Diehl (16 shared papers)Ursula Kapp (3 shared papers)Heribert Bohlen (4 shared papers)Daniel Ré (3 shared papers)Ralf Küppers (2 shared papers)Holger Kanzler (2 shared papers)Klaus Rajewsky (1 shared paper)M-L Hansmann (1 shared paper)
- Journals
- Annals of Oncology (12 papers)Journal of Clinical Oncology (9 papers)Blood (3 papers)Journal of Thoracic Oncology (3 papers)British Journal of Cancer (2 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Juergen Wolf
49 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 85
- Pathology and Forensic Medicine 552
- Oncology 472
- Immunology 216
- Genetics 104
- Radiology, Nuclear Medicine and Imaging 200
Countries citing papers authored by Juergen Wolf
This map shows the geographic impact of Juergen Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Wolf more than expected).
Fields of papers citing papers by Juergen Wolf
This network shows the impact of papers produced by Juergen Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Wolf. The network helps show where Juergen Wolf may publish in the future.
Co-authors
The 25 scholars most cited alongside Juergen Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 152 | |
| 2 | 1996 | 133 | |
| 3 | 2001 | 99 | |
| 4 | 2007 | 89 | |
| 5 | 2002 | 75 | |
| 6 | 2001 | 67 | |
| 7 | Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins. | 1999 | 55 |
| 8 | 2003 | 52 | |
| 9 | 1993 | 39 | |
| 10 | 2018 | 36 | |
| 11 | 1997 | 35 | |
| 12 | 1997 | 32 | |
| 13 | 2016 | 31 | |
| 14 | 2008 | 27 | |
| 15 | 2023 | 25 | |
| 16 | 2012 | 25 | |
| 17 | 2002 | 24 | |
| 18 | 2019 | 22 | |
| 19 | 2004 | 21 | |
| 20 | 1998 | 18 |
About Juergen Wolf
Juergen Wolf is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 56 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (13 papers), Viral-associated cancers and disorders (10 papers), Lung Cancer Research Studies (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (552 citations), Oncology (472 citations), Immunology (216 citations), Genetics (104 citations) and Radiology, Nuclear Medicine and Imaging (200 citations). Juergen Wolf has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Volker Diehl, Ursula Kapp, Heribert Bohlen, Daniel Ré, Ralf Küppers, Holger Kanzler, Klaus Rajewsky, M-L Hansmann, Sascha Ansén and Thomas Zander. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Blood, Journal of Thoracic Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.